進行性前立腺癌に対する血中オステオカルシンの臨床的意義
スポンサーリンク
概要
- 論文の詳細を見る
1)前立腺癌患者で多発性骨転移を有するA群15例,2)前立腺癌で転移のないB群12名,3)対照としての前立腺肥大症C群51例,平均年齢は72.1歳,71.7歳,70.4歳であった.血中オステオカルシン(OC)(正常値2.5～8.5 ng/ml)は10.8, 5.7, 5.8 ng/mlでAB間は有意差(p≦0.05),AC間も同様であったが,転移を有する前立腺癌は治療後OC値の下降傾向を示したThe clinical significance of osteocalcin as a marker for advanced prostate cancer was examined. Osteocalcin is produced by osteoblasts and is also detected in the blood. Its change is a good index of osteometabolic diseases and especially of the osteoblastic activity. In the present study, we examined the serum osteocalcin concentration of those patients with urogenital tumor, especially prostate cancer, who had been confirmed for multiple bone-metastasis by clinical examination. These patients comprised an untreated group (15 cases) of patients with prostate cancer presenting confirmed bone-metastasis, and a group of patients without bone-metastasis. The respective serum osteocalcin concentrations of these two groups were compared with 51 cases of prostate hypertrophy used as the control group. The findings revealed that the serum osteocalcin concentration demonstrated high values in the first group with a tendency toward lowering during treatment. Neither the latter group nor the control group showed high values. On the other hand, false-positive cases (8%), and false-negative cases (20%) were found. In the case of bone-metastasis, these results suggest that measurement of serum osteocalcin concentration is useful for clinical periodical observation about the activity of the bone metastatic focus.
論文 | ランダム
- 202. Mgの子宮筋収縮におよぼす影響 (II 一般演題 第7群 妊娠. 妊娠中毒症. 分娩)
- 38. 摘出子宮筋のOxytocin および Acetylcholineに対する感受性の比較
- Anaplastic lymphoma kinase(ALK)免疫染色が診断に必要であった膀胱の炎症性筋線維芽細胞性腫瘍(Inflammatory myofibroblastic tumor)の1例
- MP-270 限局性腎癌(T1-3NOMO)における再発予測因子としての術前CRPの有用性(一般演題ポスター,第94回日本泌尿器科学会総会)
- OP-196 前立腺癌に対するI-125シード線源による小線源治療の経験(一般演題口演,第94回日本泌尿器科学会総会)